Akoya Biosciences (AKYA) News Today $1.29 0.00 (0.00%) As of 07/8/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AKYA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period AKYA Akoya Biosciences, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Rating of "Hold" from BrokeragesJune 23, 2025 | marketbeat.comAKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYAJune 20, 2025 | prnewswire.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Hold" from BrokeragesMay 30, 2025 | marketbeat.comKent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative ProposalMay 23, 2025 | prnewswire.comAkoya surges as unsolicited buyout offer risks Quanterix mergerMay 21, 2025 | msn.comAkoya Biosciences (NASDAQ:AKYA) Releases Earnings Results, Misses Expectations By $0.03 EPSMay 14, 2025 | marketbeat.comAkoya Biosciences Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comAKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYAMay 7, 2025 | businesswire.comAkoya Biosciences (AKYA) to Release Quarterly Earnings on MondayMay 7, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Recommendation of "Hold" by AnalystsMay 6, 2025 | marketbeat.comCanaccord Genuity Group Cuts Akoya Biosciences (NASDAQ:AKYA) Price Target to $1.80May 1, 2025 | marketbeat.comAkoya Unveils ADC Breast Cancer Assay, Validates IO60 Spatial Panel At AACR 2025April 26, 2025 | nasdaq.comAkoya expands portfolio with new ADC breast cancer assay at AACR 2025April 24, 2025 | markets.businessinsider.comAkoya Biosciences, Enable Medicine launch single-cell spatial proteomics atlasApril 24, 2025 | markets.businessinsider.comAkoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics AtlasApril 24, 2025 | globenewswire.comAkoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025April 24, 2025 | globenewswire.comAkoya Biosciences, STCC partner on SUPER study for cancer immunophenotypingApril 23, 2025 | markets.businessinsider.comAkoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in SingaporeApril 23, 2025 | globenewswire.comAkoya Biosciences (NASDAQ:AKYA) Price Target Cut to $1.65 by Analysts at Piper SandlerApril 16, 2025 | marketbeat.comPiper Sandler Remains a Hold on Akoya Biosciences (AKYA)April 15, 2025 | markets.businessinsider.comAkoya Biosciences price target lowered to $1.65 from $2.40 at Piper SandlerApril 15, 2025 | markets.businessinsider.comTikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya BiosciencesApril 14, 2025 | finance.yahoo.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of "Hold" by AnalystsApril 10, 2025 | marketbeat.comKent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled AkoyaApril 7, 2025 | uk.finance.yahoo.comKent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled AkoyaApril 7, 2025 | businesswire.comQuanterix: Still Many, Many QuestionsApril 2, 2025 | seekingalpha.comAkoya Biosciences, Team SAMBAI announce selection of PhenoCycler-FusionApril 2, 2025 | markets.businessinsider.comAkoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer InequitiesApril 2, 2025 | globenewswire.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in MarchMarch 30, 2025 | marketbeat.comAkoya Biosciences downgraded to Equal Weight from Overweight at StephensMarch 27, 2025 | markets.businessinsider.comTikvah intends to vote against Quanterix’s proposed merger with AkoyaMarch 26, 2025 | markets.businessinsider.comAkoya Biosciences (NASDAQ:AKYA) Given Equal Weight Rating at StephensMarch 26, 2025 | marketbeat.comStephens & Co. Downgrades Akoya Biosciences (AKYA)March 26, 2025 | msn.comTikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya BiosciencesMarch 24, 2025 | finance.yahoo.comAkoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from StephensMarch 19, 2025 | marketbeat.comAkoya Biosciences (AKYA) Receives a Hold from Craig-HallumMarch 18, 2025 | markets.businessinsider.comAkoya Biosciences (NASDAQ:AKYA) Releases Earnings Results, Misses Estimates By $0.02 EPSMarch 18, 2025 | marketbeat.comKent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings CallMarch 17, 2025 | tmcnet.comAkoya Biosciences reports Q4 EPS (17c), consensus (16c)March 17, 2025 | markets.businessinsider.comAkoya Reports Fourth Quarter of 2024 and Full Year Financial ResultsMarch 17, 2025 | globenewswire.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of "Hold" by BrokeragesMarch 15, 2025 | marketbeat.comAkoya Biosciences downgraded to Neutral from Overweight at Piper SandlerMarch 5, 2025 | markets.businessinsider.comSVB Wealth LLC Buys Shares of 515,398 Akoya Biosciences, Inc. (NASDAQ:AKYA)March 3, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 60.1% in FebruaryMarch 2, 2025 | marketbeat.comAkoya Biosciences (AKYA) Projected to Post Earnings on MondayFebruary 24, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Recommendation of "Hold" from AnalystsFebruary 18, 2025 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest UpdateFebruary 17, 2025 | marketbeat.comAkoya Biosciences unveils strategic product roadmapFebruary 6, 2025 | markets.businessinsider.comAkoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology PanelsFebruary 5, 2025 | globenewswire.com Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address AKYA Media Mentions By Week AKYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKYA News Sentiment▼0.930.97▲Average Medical News Sentiment AKYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKYA Articles This Week▼12▲AKYA Articles Average Week Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MASS News Today FEIM News Today KEQU News Today RPID News Today OWLT News Today SEER News Today NAUT News Today PRE News Today INTT News Today OPXS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKYA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.